Navigation Links
New Zealand’s Pharmac Subsidies Two More HIV Drug

The New Zealand Aids Foundation has welcomed a decision by Pharmac(the Pharmaceutical Schedule agency) to subsidize two new HIV drugs//. At the same time, they say delays over the funding may shorten some sufferers' lives.

The two new medicines, to be subsidized from April 1, 2007 are Tenofovir (Viread) and emtricitabine (Emtriva), Pharmac announced.

According to Pharmac’s medical director Dr Peter Moodie the investment would cost about $1.5 million over five years, and up to 159 HIV patients would be eligible for treatment within three years.

While Tenofovir and emtricitabine are similar to drugs already funded by the drug agency, funding them is important because HIV can become resistant to existing treatments, says Moodie.

Tenofovir is reported to have fewer side effects for some patients.

Says Aids Foundation positive health manager Eamonn Smythe: "In New Zealand, tenofovir was approved by (medicines regulator) Medsafe in November 2005, but HIV-positive patients have been unable to access it sooner due to delays in Pharmac and manufacturer Gilead reaching a suitable funding compromise."

Smythe reports HIV as a complex virus, which changes rapidly and necessitates new medications, to be made available to sufferers quickly, after testing and approval.

"Delays of this kind can affect the quality of life, and even life expectancy, of HIV-positive patients," he re-iterates.

According to Aids Foundation estimates, just over 2000 people in New Zealand have been diagnosed with HIV, and the count is rising ,especially among gay and bisexual men.

"One hundred and seventy seven new diagnoses were recorded overall in 2006, the second-highest number ever reported in New Zealand for a single year,” says Smythe.

Smythe also added that the two new drugs caused nausea, vomiting and fatigue, though considerably lower than other HIV drugs.

"Living with the side effe cts of HIV medication is not always an easy ride, despite the advances made in recent years," says Smythe.

Yet, prevention is better than cure or treatment, in this case. “ For HIV-negative people, it's important to remember that avoiding infection in the first place is still the best weapon we have against HIV (which) means always using condoms’, Smythe advises.
NN
'"/>




Related medicine news :

1. New Zealand’s Medical Lab Workers On Strik
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Medicis Pharmaceutical company enters pediatric market
5. Pharmacies in for a dose of bitter medicine
6. Pharmacia may take 51.5 percent Abbott stake
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Pharmacist’s Role in Medication Error
10. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
11. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... ... , ... CDRH Enforcement Trends: , Back to the Future , Feb. 25, 2016 — 11:00 ... said, “Those who don’t learn from history are doomed to repeat it.” , An analysis ... this year. But that takes time. , Take a close look at the warning ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of coconut water beverages ... GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature ... event. The invitation-only gifting suite, held this year at the W Hollywood Hotel, has ...
(Date:2/12/2016)... ... ... Every winter, someone is killed, injured or loses a home in an accident ... of the Allegheny Health Network, has partnered with Etna Volunteer Fire Department, and Monroeville ... , “Space Heaters Need Space” aims to bring awareness to the risks ...
(Date:2/12/2016)... ... February 12, 2016 , ... Vail knee specialist ... Leaders to Know in 2016 . The list consists of physicians establishing, leading and ... establish this list. , An Ambulatory Surgery Center, also known as an ASC, ...
(Date:2/12/2016)... ... 12, 2016 , ... Miami Dental Specialists is excited to bring patients the ... Beginning in January, Miami Dental Specialists will offer the non-metal implants as a safe, ... to be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge technology ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
(Date:2/11/2016)... -- The primary goal of this research is to ... usage of liquid biopsy. Key information the survey seeks ... of liquid biopsy adoption amidst future users - Predominantly ... - Sample inflow to conduct liquid biopsy tests - ... so on. - Correlation analysis of sample type and ...
Breaking Medicine Technology: